RadNet and Whiterabbit.ai Form a Comprehensive Partnership to Address Mammography Compliance and Improved Diagnostics for Bre...
November 07 2019 - 6:00AM
RadNet, Inc. (NASDAQ: RDNT), a national leader in
providing high-quality, cost-effective, fixed-site outpatient
diagnostic imaging services today reported it has created a
multifaceted partnership with Whiterabbit.ai utilizing artificial
intelligence, other technologies and operational protocols to
address solutions for breast cancer imaging.
The partnership initially will focus on
processes and technology designed to improve compliance of women
with respect to their annual or bi-annual screening mammography
exams. The two companies recently completed a pilot program
in RadNet’s Delaware and Florida markets which combined the use of
machine learning and patient outreach to bring women into RadNet
facilities for their screening exams. The trial substantially
increased patient compliance, improved operational protocols and
drove a level of customer service more similar to other
consumer-facing industries.
Based upon the success of the pilot program,
RadNet has licensed the Whiterabbit.ai technology and back-end
operational platform. Together, RadNet and Whiterabbit.ai
plan to deploy the platform to all other RadNet markets during the
first half of 2020. In addition to the system-wide roll-out
and platform licensing arrangement, RadNet has made an equity
investment in Whiterabbit.ai and will work with Whiterabbit.ai to
develop future solutions, including personal computer and mobile
phone applications and artificial intelligence algorithms to
automate the interpretation of mammography images.
Dr. Howard Berger, Chairman and Chief Executive
Officer of RadNet, noted, “The partnership arrangement with, and
investment in Whiterabbit.ai reiterates our commitment to position
RadNet with cutting-edge technology solutions that we believe will
transform our industry in the coming years. We expect that
machine learning, big data applications and automation algorithms
will help us to deliver our services more cost effectively,
efficiently and accurately, while enhancing the patient
experience.”
Dr. Berger continued, “We are pleased to
formalize our relationship with Whiterabbit.ai as a customer,
investor and future development partner. Having measured
demonstrable success during our pilot phase, we are optimistic that
we can create similar improvements in our other markets as we
deploy Whiterabbit.ai technology throughout RadNet’s regional
operations.”
Rakesh Mathur, Whiterabbit.ai founder and Chief
Executive Officer noted, “We are thrilled that Radnet, the largest
U.S. owner and operator of diagnostic imaging centers, is the first
customer for our AI Radiology suite. Radnet shares our
mission to improve the early detection and diagnostics of breast
disease, and ultimately reduce suffering by materially reducing the
incidence of late-stage cancers. We are working with RadNet’s
team to create solutions consistent with our shared visions of
customer-focused medicine and attention to the patient
experience. The objectives of our collaboration with RadNet
are to improve mammography compliance by women across the country,
enhance their imaging center experience and drive more positive
outcomes through early detection.”
About RadNet, Inc.
RadNet, Inc. is the leading national provider of freestanding,
fixed-site diagnostic imaging services in the United States based
on the number of locations and annual imaging revenue. RadNet has a
network of 340 owned and/or operated outpatient imaging centers.
RadNet's core markets include California, Maryland, Delaware, New
Jersey and New York. In addition, RadNet provides radiology
information technology solutions, teleradiology professional
services and other related products and services to customers in
the diagnostic imaging industry. Together with affiliated
radiologists, and inclusive of full-time and per diem employees and
technicians, RadNet has a total of over 8,000 employees. For more
information, visit http://www.radnet.com.
About Whiterabbit.ai
Whiterabbit.ai is dedicated to developing robust AI technologies
to improve the speed and accuracy of cancer detection in radiology.
The company is developing solutions to increase compliance,
eliminate stress and anxiety for women, increase early detection,
improve outcomes and reduce costs, while treating patients as
consumers. The company’s AI-enabled technologies could help
effectively eradicate late-stage breast cancers in the United
States. Whiterabbit.ai is based in the heart of Silicon Valley.
This announcement with RadNet marks the end of Whiterabbit.ai’s
stealth period. Learn more at www.whiterabbit.ai.
CONTACTS:
RadNet,
Inc.Mark Stolper,
310-445-2800Executive Vice
President and Chief Financial Officer
Ann
RowellWhiterabbit.aiAnn@whiterabbit.ai602.545.5530
RadNet (NASDAQ:RDNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
RadNet (NASDAQ:RDNT)
Historical Stock Chart
From Apr 2023 to Apr 2024